These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18317653)

  • 1. [Descriptive analysis of the social, clinical, laboratorial and anthropometric profiles of inflammatory bowel disease inwards patients from the "Clementino Fraga Filho" University Hospital, Rio de Janeiro, RJ, Brazil].
    Elia PP; Fogaça HS; Barros RG; Zaltman C; Elia CS
    Arq Gastroenterol; 2007; 44(4):332-9. PubMed ID: 18317653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trends in the occurrence (1980-1999) and clinical features of Crohn's disease and ulcerative colitis in a university hospital in southeastern Brazil].
    Souza MH; Troncon LE; Rodrigues CM; Viana CF; Onofre PH; Monteiro RA; Passos AD; Martinelli AL; Meneghelli UG
    Arq Gastroenterol; 2002; 39(2):98-105. PubMed ID: 12612713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INFLAMMATORY BOWEL DISEASE: OUTPATIENT TREATMENT PROFILE.
    Santos RMD; Carvalho ATP; Silva KDS; Sá SPC; Santos AHD; Sandinha MR
    Arq Gastroenterol; 2017; 54(2):96-100. PubMed ID: 28198912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables.
    Alves RA; Miszputen SJ; Figueiredo MS
    Sao Paulo Med J; 2014; 132(3):140-6. PubMed ID: 24760213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS.
    Nóbrega VG; Silva INN; Brito BS; Silva J; Silva MCMD; Santana GO
    Arq Gastroenterol; 2018; 55(3):290-295. PubMed ID: 30540094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients.
    Greenstein AJ; Janowitz HD; Sachar DB
    Medicine (Baltimore); 1976 Sep; 55(5):401-12. PubMed ID: 957999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease.
    Bengi G; Keyvan H; Durmaz SB; Akpınar H
    World J Gastroenterol; 2018 Sep; 24(36):4186-4196. PubMed ID: 30271083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall and cause-specific mortality in Korean patients with inflammatory bowel disease: A hospital-based cohort study.
    Lee HS; Choe J; Kim SO; Lee SH; Lee HJ; Seo H; Kim GU; Seo M; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH; Yang SK
    J Gastroenterol Hepatol; 2017 Apr; 32(4):782-788. PubMed ID: 27637573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.
    Neubauer K; Kempinski R; Matusiewicz M; Bednarz-Misa I; Krzystek-Korpacka M
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30986917
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy.
    Gasparetto M; Guariso G; Pozza LV; Ross A; Heuschkel R; Zilbauer M
    BMC Gastroenterol; 2016 Mar; 16():35. PubMed ID: 26976427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric inflammatory bowel disease in New Zealand.
    Yap J; Wesley A; Mouat S; Chin S
    N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
    Nos P; Argüello L; Hoyos M; Ramírez JJ; Hinojosa J; Molés JR; García A; Berenguer M; Berenguer J
    Rev Esp Enferm Dig; 1996 Jul; 88(7):470-4. PubMed ID: 8924324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use.
    Herrlinger KR; Noftz MK; Fellermann K; Schmidt K; Steinhoff J; Stange EF
    Aliment Pharmacol Ther; 2001 Mar; 15(3):363-9. PubMed ID: 11207511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.
    Parente JM; Coy CS; Campelo V; Parente MP; Costa LA; da Silva RM; Stephan C; Zeitune JM
    World J Gastroenterol; 2015 Jan; 21(4):1197-206. PubMed ID: 25632193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.